An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules

Dao, T; Korontsvit, T; Zakhaleva, V; Jarvis, C; Mondello, P; Oh, C; Scheinberg, DA

Scheinberg, DA (reprint author), 417 East 68 St,Z-1960, New York, NY 10017 USA.

ONCOIMMUNOLOGY, 2017; 6 (2):

Abstract

The Wilms' tumor oncogene protein (WT1) is a highly validated tumor antigen for immunotherapy. WT1-targeted immunotherapy has been extensively explore......

Full Text Link